Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6052685 | 0.90 | DGKA (0.62) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL16800412 | 0.90 | DGKA (0.62) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL505106 | 0.90 | DGKA (0.62) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL6052723 | 0.90 | DGKA (0.62) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL17212329 | 0.90 | DGKA (0.67) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL7879521 | 0.90 | DGKA (0.67) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL6904892 | 0.90 | DGKA (0.67) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL3815253 | 0.90 | DGKA (0.67) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL3692173 | 0.90 | DGKA (0.67) | DGKAMEN1KMT2ALMNAKDM4E | |
| SCHEMBL28292733 | 0.89 | DGKA (0.61) | DGKAMEN1KMT2ALMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1962591-B1 | FORMULATIONS OF BIFENTHRIN AND ENRICHED CYPERMETHRIN | FMC CORP (US) | 2016-07-27 | — | — | EP | claimed |
| US-8349344-B2 | Formulations of bifenthrin and enriched cypermethrin | FMC CORPORATION (US) | 2013-01-08 | — | — | US | claimed |
| US-20120172428-A1 | Novel Formulations of Bifenthrin and Enriched Cypermethrin | FMC CORPORATION (US) | 2012-07-05 | — | — | US | claimed |
| US-20090170935-A1 | Novel Formulations of Bifenthrin and Enriched Cypermethrin | FMC CORPORATION | 2009-07-02 | — | — | US | claimed |
| EP-1962591-A2 | NOVEL FORMULATIONS OF BIFENTHRIN AND ENRICHED CYPERMETHRIN | FMC CORPORATION (US) | 2008-09-03 | — | — | EP | claimed |
| WO-2007076027-A2 | NOVEL FORMULATIONS OF BIFENTHRIN AND ENRICHED CYPERMETHRIN | FMC CORPORATION (US) | 2007-07-05 | — | — | WO | claimed |
| EP-3009000-A1 | FORMULATIONS OF BIFENTHRIN AND ENRICHED CYPERMETHRIN | FMC Corporation (US) | 2016-04-20 | — | — | EP | disclosed |